[go: up one dir, main page]

FI973571A - Uusi kasvutekijä ja sitä koodaava geneettinen sekvenssi - Google Patents

Uusi kasvutekijä ja sitä koodaava geneettinen sekvenssi Download PDF

Info

Publication number
FI973571A
FI973571A FI973571A FI973571A FI973571A FI 973571 A FI973571 A FI 973571A FI 973571 A FI973571 A FI 973571A FI 973571 A FI973571 A FI 973571A FI 973571 A FI973571 A FI 973571A
Authority
FI
Finland
Prior art keywords
sequence encoding
genetic sequence
new plant
plant factor
molecule
Prior art date
Application number
FI973571A
Other languages
English (en)
Swedish (sv)
Other versions
FI973571A0 (fi
FI120153B (fi
Inventor
Nicholas Kim Hayward
Gunther Weber
Sean Grimmond
Magnus Nordenskjold
Catharina Larsson
Original Assignee
Amrad Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPN1457A external-priority patent/AUPN145795A0/en
Priority claimed from AUPN6647A external-priority patent/AUPN664795A0/en
Priority claimed from AUPN7274A external-priority patent/AUPN727495A0/en
Application filed by Amrad Operations Pty Ltd filed Critical Amrad Operations Pty Ltd
Publication of FI973571A0 publication Critical patent/FI973571A0/fi
Publication of FI973571A publication Critical patent/FI973571A/fi
Application granted granted Critical
Publication of FI120153B publication Critical patent/FI120153B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI973571A 1995-03-02 1997-09-01 Uusi kasvutekijä ja sitä koodaava geenisekvenssi FI120153B (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
AUPN145795 1995-03-02
AUPN1457A AUPN145795A0 (en) 1995-03-02 1995-03-02 A novel growth factor and a genetic sequence encoding same
AUPN664795 1995-11-20
AUPN6647A AUPN664795A0 (en) 1995-11-20 1995-11-20 A novel growth factor and a genetic sequence encoding same
AUPN7274A AUPN727495A0 (en) 1995-12-22 1995-12-22 A novel growth factor and a genetic sequence encoding same-II
AUPN727495 1995-12-22
PCT/AU1996/000094 WO1996027007A1 (en) 1995-03-02 1996-02-22 A novel growth factor and a genetic sequence encoding same
AU9600094 1996-02-22

Publications (3)

Publication Number Publication Date
FI973571A0 FI973571A0 (fi) 1997-09-01
FI973571A true FI973571A (fi) 1997-10-30
FI120153B FI120153B (fi) 2009-07-15

Family

ID=27157841

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973571A FI120153B (fi) 1995-03-02 1997-09-01 Uusi kasvutekijä ja sitä koodaava geenisekvenssi

Country Status (16)

Country Link
US (1) US20070135344A1 (fi)
EP (1) EP0815221B1 (fi)
JP (2) JPH11500139A (fi)
KR (1) KR100414615B1 (fi)
CN (1) CN1194090C (fi)
AT (1) ATE252600T1 (fi)
BR (1) BR9607628A (fi)
CA (1) CA2214439C (fi)
DE (1) DE69630442T2 (fi)
ES (1) ES2206558T3 (fi)
FI (1) FI120153B (fi)
HK (1) HK1002963A1 (fi)
HU (1) HU223438B1 (fi)
NO (1) NO320839B1 (fi)
NZ (2) NZ301611A (fi)
WO (1) WO1996027007A1 (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928939A (en) * 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor
EP0873348A4 (en) * 1995-06-06 2000-11-08 Human Genome Sciences Inc GROWTH FACTOR 3 OF THE HUMAN VASCULAR ENDOTHELIUM
PT848755E (pt) 1995-09-08 2003-12-31 Genentech Inc Proteina relacionada com o vegf
ATE459715T1 (de) 1995-09-29 2010-03-15 Univ Siena Regulierte gene und ihre verwendungen
WO1997017442A1 (en) 1995-11-08 1997-05-15 Immunex Corporation Flk-1 binding protein
US6994989B1 (en) 1995-11-08 2006-02-07 Immunex Corp. FLK-1 binding proteins
DK0956339T3 (da) 1996-08-23 2006-01-30 Licentia Oy Rekombinant vaskulær endotelcellevækstfaktor D (VEGF-D)
EP0977854A2 (en) * 1997-04-25 2000-02-09 Collateral Therapeutics Truncated vegf-related proteins
US6479654B1 (en) 1998-02-06 2002-11-12 Collateral Therapeutics Forms of the angiogenic factor vascular endothelial cell growth factor: VEGF
EP2151454B1 (en) 1998-11-10 2012-05-02 Ludwig Institute For Cancer Research Truncated platelet-derived growth factor D, DNA coding therefor, and uses thereof
US7105481B2 (en) 1998-11-10 2006-09-12 Ludwig Institute For Cancer Research Method for stimulating connective tissue growth or wound healing
ES2312223T3 (es) 1998-12-07 2009-02-16 Zymogenetics, Inc. Zvegf3 homologo de factor de crecimiento.
US6783953B1 (en) 1998-12-22 2004-08-31 Janssen Pharmaceutica N.V. Vascular endothelial growth factor-X
AUPQ568100A0 (en) * 2000-02-16 2000-03-09 Amrad Operations Pty. Limited A method for producing recombinant molecules
AU2884102A (en) 2000-12-07 2002-06-18 Sangamo Biosciences Inc Regulation of angiogenesis with zinc finger proteins
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7981863B2 (en) * 2001-09-19 2011-07-19 Neuronova Ab Treatment of Parkinson's disease with PDGF
WO2006094106A2 (en) 2005-02-28 2006-09-08 Sangamo Biosciences, Inc. Anti-angiogenic methods and compositions
CN100448892C (zh) * 2006-08-02 2009-01-07 中国人民解放军军事医学科学院基础医学研究所 抗肿瘤血管内皮生长因子受体vegf-r2抗原及其编码基因与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073492A (en) * 1987-01-09 1991-12-17 The Johns Hopkins University Synergistic composition for endothelial cell growth
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5219739A (en) * 1989-07-27 1993-06-15 Scios Nova Inc. DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121
US5338671A (en) * 1992-10-07 1994-08-16 Eastman Kodak Company DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody
ES2249762T3 (es) * 1994-03-08 2006-04-01 Human Genome Sciences, Inc. Factor de crecimiento del endotelio vascular 2.
US5607918A (en) * 1995-03-01 1997-03-04 Ludwig Institute For Cancer Research Vascular endothelial growth factor-B and DNA coding therefor
US5928939A (en) * 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor

Also Published As

Publication number Publication date
CN1224464A (zh) 1999-07-28
HUP9800377A1 (hu) 1998-06-29
ATE252600T1 (de) 2003-11-15
EP0815221B1 (en) 2003-10-22
FI973571A0 (fi) 1997-09-01
JPH11500139A (ja) 1999-01-06
NO974035L (no) 1997-11-03
NO320839B1 (no) 2006-01-30
DE69630442T2 (de) 2004-08-19
JP3683778B2 (ja) 2005-08-17
NZ301611A (en) 2000-02-28
NO974035D0 (no) 1997-09-02
US20070135344A1 (en) 2007-06-14
NZ337634A (en) 2001-06-29
ES2206558T3 (es) 2004-05-16
CA2214439A1 (en) 1996-09-06
EP0815221A1 (en) 1998-01-07
HUP9800377A3 (en) 2000-12-28
DE69630442D1 (de) 2003-11-27
KR19980702702A (ko) 1998-08-05
FI120153B (fi) 2009-07-15
BR9607628A (pt) 1999-11-30
EP0815221A4 (en) 1998-12-09
KR100414615B1 (ko) 2004-05-27
JP2001037493A (ja) 2001-02-13
HU223438B1 (hu) 2004-07-28
CN1194090C (zh) 2005-03-23
WO1996027007A1 (en) 1996-09-06
CA2214439C (en) 2002-12-17
HK1002963A1 (en) 1998-09-30

Similar Documents

Publication Publication Date Title
FI973571A (fi) Uusi kasvutekijä ja sitä koodaava geneettinen sekvenssi
DE69434312D1 (de) Regulierung von pflanzenwachstum
ATE189475T1 (de) Wachstums-differenzierungsfaktor der tgf-b familie
DK0851874T3 (da) Hidtil ukendte varianter af grønt fluorescerende protein, GFP
DE69602638D1 (de) Naphthylverbindungen, Zwischenprodukte, Zusammensetzungen und Methoden
CY1107447T1 (el) Ετερολογη εκφραση πρωτεϊνων των neisseria
DK0825847T3 (da) Tandrensningspræparater
EP1594889A4 (en) NELL PEPTIDE EXPRESSION SYSTEMS AND BONE-MAKING NELL PEPTIDE ACTIVITY
MY148081A (en) Cultivated agarwood
HRP20010036B1 (en) Neurotrophic growth factor
NO971875D0 (no) Cathepsin 02 protease
DE69636495D1 (de) Multi-tumor abweichende wachstumsgene
DK0938308T3 (da) Antiparasitiske midler
ATE360701T1 (de) Putrescin-n-methyltransferasepromotor
DE50004334D1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
DE69328025D1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
AU8738401A (en) Novel kallikrein gene
DE50111331D1 (de) Neue verwendung von proteinhydrolysaten
BR9711540A (pt) Inibidores de protease proteìnico estabilizados e variantes dos mesmos
DE69938130D1 (de) Neue peptide
FI944563A0 (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö
DE69826029D1 (de) Acetyl-coa-carboxylase von candida albicans
ATE376586T1 (de) Ppgpp-synthetase und expressionssysteme zur verbesserten herstellung von proteinen
DE69838459D1 (de) Für den licht-überempfinlichkeitsphaenotyp kodierende nukleotidsequenzen von tomaten, dadurch kodierte proteine und deren verwendungen
FR2654430B1 (fr) Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120153

Country of ref document: FI

MA Patent expired